Precision Bio Sciences Promotes Naresh Tanna To Vice President of Investor Relations

Feb 13, 2024•almost 2 years ago

Company

Precision BioSciences

DurhamGeneticsTherapeuticsBiotechnologyHealth Care

Description

Precision BioSciences, Inc. announced the promotion of Naresh Tanna from Chief of Staff to the CEO to Vice President of Investor Relations to enhance and expand its IR program and communications with shareholders.

Company Information

Company

Precision BioSciences

Location

302 EAST PETTIGREW STREET

Durham, North Carolina, United States

About

Precision is a clinical stage gene editing company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform that differs from other technologies in the way it cuts, its smaller size, and its simpler structure. Key capabilities and differentiating characteristics may enable ARCUS nucleases to drive more intended, defined therapeutic outcomes. Using ARCUS, Precision’s pipeline is comprised of in vivo gene editing candidates designed to deliver lasting cures for the broadest range of genetic and infectious diseases where no adequate treatments exist.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months

Precision Bio Sciences Promotes Naresh Tanna To Vice President of Investor Relations

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Executive Insights

Company Information